scholarly journals Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study

2022 ◽  
Vol 30 ◽  
pp. 100838
Author(s):  
Renzo Mignani ◽  
Federico Pieruzzi
Keyword(s):  
Fabry Disease ◽  
Infusion Time ◽  
Agalsidase Beta ◽  
Multi Centre Study ◽  
Centre Study

2357Novel electrocardiographic parameters for the detection of Fabry Disease - A comparative multi-centre study

2018 ◽  
Vol 39 (suppl_1) ◽  
Author(s):  
M Namdar ◽  
P H Richardot ◽  
I Olivotto ◽  
P Nordbeck ◽  
P MacFarlane
Keyword(s):  
Fabry Disease ◽  
Multi Centre Study ◽  
Centre Study ◽  
Electrocardiographic Parameters

scholarly journals Reduction of agalsidase beta infusion time in patients with fabry disease: A case series report and suggested protocol

2021 ◽  
pp. 100755
Author(s):  
Aquilino Sánchez-Purificación ◽  
Aránzazu Castellano ◽  
Belén Gutiérrez ◽  
Marta Gálvez ◽  
Beatriz Díaz ◽  
...  
Keyword(s):  
Fabry Disease ◽  
Case Series ◽  
Infusion Time ◽  
Agalsidase Beta ◽  
Case Series Report ◽  
Series Report

scholarly journals Atrial fibrillation prevalence and risk profile from novel community-based screening in Thailand: A prospective multi-centre study

2021 ◽  
Vol 32 ◽  
pp. 100709
Author(s):  
Nijasri C. Suwanwela ◽  
Aurauma Chutinet ◽  
Hathairat Autjimanon ◽  
Tanawat Ounahachok ◽  
Chumpol Decha-umphai ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Risk Profile ◽  
Community Based ◽  
Multi Centre Study ◽  
Centre Study

Dual therapy with migalastat and agalsidase-beta in a patient with Fabry disease with progressing hypertrophic cardiomyopathy

2021 ◽  
Vol 132 (2) ◽  
pp. S103
Author(s):  
Chanan Stauffer ◽  
Manisha Balwani ◽  
Robert J. Desnick ◽  
Luca Fierro ◽  
Jaya Ganesh
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Fabry Disease ◽  
Dual Therapy ◽  
Agalsidase Beta
Sign in / Sign up

Export Citation Format

Share Document